For example, RT has been shown to upregulate the expression of the immune checkpoint PD‐L1 in both preclinical (Deng et al., 2014) and clinical settings (Twyman‐Saint Victor et al., 2015), thus limiting the activation of tumour T cells. Here, CD274 is linked to neoplasm.